Reducing Chemotherapy Waiting Times in the Ambulatory Setting of a Tertiary Cancer Centre Using a Design Thinking Approach

by Jen, Wei-Ying, Chan, Zhi Yao, Lee, Yee Mei, Ng, Noel, Tan, Belinda, Teo, Constance, Wong, Yuet Peng, Chee, Cheng Ean, Chee, Yen-Lin
Published 2023

Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors

by Lim, Jhin Jieh, Hooi, Lissa, Dan, Yock Young, Bonney, Glenn K, Zhou, Lei, Chow, Pierce K-H, Chee, Cheng Ean, Toh, Tan Boon, Chow, Edward K-H
Published 2023

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin +/- Trastuzumab in Advanced Solid Tumors

by Lee, Matilda Xinwei, Wong, Andrea LA, Ow, Samuel, Sundar, Raghav, Tan, David SP, Soo, Ross A, Chee, Cheng Ean, Lim, Joline SJ, Yong, Wei Peng, Lim, Siew Eng, Goh, Boon Cher, Wang, Lingzhi, Lee, Soo Chin
Published 2022

A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in...

by Ho, Jingshan, Heong, Valerie, Yong, Wei Peng, Soo, Ross, Chee, Cheng Ean, Wong, Andrea, Sundar, Raghav, Thian, Yee Liang, Gopinathan, Anil, Pang, Mei Yan, Koe, Priscillia, Jeraj, Santhiay Nathan, Soe, Phyu Pyar, Soe, Mu Yar, Tang, Tiffany, Ng, Matthew CH, Tai, David WM, Tan, Tira JY, Xu, Hongmei, Chang, Hua, Landesman, Yosef, Shah, Jatin, Shacham, Sharon, Lee, Soo Chin, Tan, Daniel SW, Goh, Boon Cher, Tan, David SP
Published 2022

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

by Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi
Published 2019

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)

by Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi
Published 2021

Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine Initiatives

by Jain, Sneha Rajiv, Sim, Wilson, Ng, Cheng Han, Chin, Yip Han, Lim, Wen Hui, Syn, Nicholas L., Kamal, Nur Haidah Bte Ahmad, Gupta, Mehek, Heong, Valerie, Lee, Xiao Wen, Sapari, Nur Sabrina, Koh, Xue Qing, Isa, Zul Fazreen Adam, Ho, Lucius, O’Hara, Caitlin, Ulagapan, Arvindh, Gu, Shi Yu, Shroff, Kashyap, Weng, Rei Chern, Lim, Joey S. Y., Lim, Diana, Pang, Brendan, Ng, Lai Kuan, Wong, Andrea, Soo, Ross Andrew, Yong, Wei Peng, Chee, Cheng Ean, Lee, Soo-Chin, Goh, Boon-Cher, Soong, Richie, Tan, David S. P.
Published 2022